RAMSAY GENERALE DE SANTE SA (GDS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:GDS - FR0000044471 - Common Stock
9.02 EUR
+0.02 (+0.22%)
Overall GDS gets a fundamental rating of 2 out of 10. We evaluated GDS against 29 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of GDS have multiple concerns. GDS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
GDS had negative earnings in the past year.
GDS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: GDS reported negative net income in multiple years.
Each year in the past 5 years GDS had a positive operating cash flow.
1.2 Ratios
GDS has a worse Return On Assets (-0.79%) than 86.21% of its industry peers.
With a Return On Equity value of -4.72%, GDS is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
GDS has a worse Return On Invested Capital (2.64%) than 75.86% of its industry peers.
GDS had an Average Return On Invested Capital over the past 3 years of 1.89%. This is below the industry average of 6.67%.
The last Return On Invested Capital (2.64%) for GDS is above the 3 year average (1.89%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -4.72% | ||
| ROIC | 2.64% |
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.89%
ROIC(5y)1.48%
1.3 Margins
GDS has a Operating Margin (3.57%) which is in line with its industry peers.
GDS's Operating Margin has improved in the last couple of years.
GDS has a Gross Margin of 77.91%. This is in the better half of the industry: GDS outperforms 79.31% of its industry peers.
In the last couple of years the Gross Margin of GDS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.57% | ||
| PM (TTM) | N/A | ||
| GM | 77.91% |
OM growth 3Y29.81%
OM growth 5Y22.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDS is destroying value.
The number of shares outstanding for GDS remains at a similar level compared to 1 year ago.
GDS has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for GDS is higher compared to a year ago.
2.2 Solvency
GDS has an Altman-Z score of 1.00. This is a bad value and indicates that GDS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.00, GDS is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
The Debt to FCF ratio of GDS is 7.41, which is on the high side as it means it would take GDS, 7.41 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.41, GDS perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
A Debt/Equity ratio of 3.27 is on the high side and indicates that GDS has dependencies on debt financing.
GDS has a Debt to Equity ratio of 3.27. This is in the lower half of the industry: GDS underperforms 75.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 7.41 | ||
| Altman-Z | 1 |
ROIC/WACC0.56
WACC4.71%
2.3 Liquidity
GDS has a Current Ratio of 0.81. This is a bad value and indicates that GDS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of GDS (0.81) is worse than 68.97% of its industry peers.
GDS has a Quick Ratio of 0.81. This is a bad value and indicates that GDS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.73, GDS is in line with its industry, outperforming 51.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
GDS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.37%.
GDS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.70%.
The Revenue has been growing slightly by 6.95% on average over the past years.
EPS 1Y (TTM)-0.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.93%
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%3.73%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
GDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
GDS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GDS is cheaper than 79.31% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GDS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.81 | ||
| EV/EBITDA | 7.52 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
GDS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:GDS (12/8/2025, 7:00:00 PM)
9.02
+0.02 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners39.92%
Inst Owner ChangeN/A
Ins Owners6.67%
Ins Owner ChangeN/A
Market Cap995.72M
Revenue(TTM)5.24B
Net Income(TTM)-54.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.19 | ||
| P/FCF | 1.81 | ||
| P/OCF | 1.44 | ||
| P/B | 0.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.52 |
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.99
FCFY55.33%
OCF(TTM)6.28
OCFY69.67%
SpS47.49
BVpS10.37
TBVpS-10.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -4.72% | ||
| ROCE | 3.59% | ||
| ROIC | 2.64% | ||
| ROICexc | 2.85% | ||
| ROICexgc | 5.42% | ||
| OM | 3.57% | ||
| PM (TTM) | N/A | ||
| GM | 77.91% | ||
| FCFM | 10.51% |
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.89%
ROIC(5y)1.48%
ROICexc(3y)2.04%
ROICexc(5y)1.59%
ROICexgc(3y)3.83%
ROICexgc(5y)2.97%
ROCE(3y)2.58%
ROCE(5y)2.01%
ROICexgc growth 3Y44.11%
ROICexgc growth 5Y31.78%
ROICexc growth 3Y41.72%
ROICexc growth 5Y29.83%
OM growth 3Y29.81%
OM growth 5Y22.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
F-Score3
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 7.41 | ||
| Debt/EBITDA | 6.03 | ||
| Cap/Depr | 32.9% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 0.99 | ||
| Cash Conversion | 111.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 1 |
F-Score3
WACC4.71%
ROIC/WACC0.56
Cap/Depr(3y)38.37%
Cap/Depr(5y)42.77%
Cap/Sales(3y)3.25%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%3.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.13%
EBIT growth 3Y38.66%
EBIT growth 5Y31.31%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.7%
FCF growth 3Y99.96%
FCF growth 5Y-0.36%
OCF growth 1Y18.22%
OCF growth 3Y38.26%
OCF growth 5Y-1%
RAMSAY GENERALE DE SANTE SA / GDS.PA FAQ
Can you provide the ChartMill fundamental rating for RAMSAY GENERALE DE SANTE SA?
ChartMill assigns a fundamental rating of 2 / 10 to GDS.PA.
Can you provide the valuation status for RAMSAY GENERALE DE SANTE SA?
ChartMill assigns a valuation rating of 2 / 10 to RAMSAY GENERALE DE SANTE SA (GDS.PA). This can be considered as Overvalued.
How profitable is RAMSAY GENERALE DE SANTE SA (GDS.PA) stock?
RAMSAY GENERALE DE SANTE SA (GDS.PA) has a profitability rating of 3 / 10.
What is the financial health of RAMSAY GENERALE DE SANTE SA (GDS.PA) stock?
The financial health rating of RAMSAY GENERALE DE SANTE SA (GDS.PA) is 1 / 10.